92
Participants
Start Date
June 30, 2006
Primary Completion Date
April 30, 2009
Study Completion Date
April 30, 2009
clarithromycin
clarithromycin 500 mg twice daily (Biaxin)
fluticasone propionate
fluticasone propionate 88 mcg twice daily (Flovent® HFA 44 mcg two puffs twice daily)
placebo clarithromycin
placebo clarithromycin twice daily
Columbia University Medical Center, New York
Wake Forest University Health Sciences, Winston-Salem
Duke University Medical Center, Durham
University of Wisconsin, Madison, Madison
Washington University, St. Louis, St Louis
University of Texas Medical Branch, Galveston
National Jewish Medical and Research Center, Denver
University of California, San Diego, San Diego
University of California, San Francisco, San Francisco
Brigham & Women's Hospital, Boston
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Milton S. Hershey Medical Center
OTHER